Consolidated Portfolio Review Corp’s Lam Research LRCX Stock Holding History

Consolidated Portfolio Review Corp’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-24,434	Closed	-$3.27M	–	247
2025 Q3	$3.27M	Buy	24,434 +188	+0.8%	+$19.9K	0.41%	62
2025 Q2	$2.36M	Buy	24,246 +2,316	+11%	+$184K	0.33%	73
2025 Q1	$1.59M	Hold	21,930	–	–	0.26%	101
2024 Q4	$1.58M	Buy	21,930 +280	+1%	+$21.2K	0.25%	104
2024 Q3	$1.77M	Buy	21,650 +50	+0.2%	+$4.35K	0.39%	65
2024 Q2	$2.3M	Hold	21,600	–	–	0.54%	45
2024 Q1	$2.1M	Sell	21,600 -2,750	-11%	-$242K	0.55%	52
2023 Q4	$1.91M	Hold	24,350	–	–	0.44%	64
2023 Q3	$1.53M	Hold	24,350	–	–	0.37%	77
2023 Q2	$1.57M	Hold	24,350	–	–	0.37%	77
2023 Q1	$1.29M	Buy	+24,350	New	+$1.19M	0.35%	77

Other funds holding LRCX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

Consolidated Portfolio Review Corp's LRCX Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of Lam Research (LRCX) in Q4 2025, closing a stake of 24,434 shares — an estimated $3.27M sold.

Consolidated Portfolio Review Corp first reported a position in LRCX in Q1 2023 and held it in 11 quarters. The position peaked at $3.27M in Q3 2025. 2,387 funds tracked by Wall St. Rank hold LRCX as of Q4 2025.

Consolidated Portfolio Review Corp reported no remaining Lam Research position as of Q4 2025 after selling out during the quarter.
Consolidated Portfolio Review Corp sold 24,434 Lam Research shares in Q4 2025, an estimated $3.27M.
Consolidated Portfolio Review Corp first reported a position in Lam Research in Q1 2023 and held it in 11 quarters.
Consolidated Portfolio Review Corp's Lam Research position peaked at $3.27M in Q3 2025.
2,387 funds tracked by Wall St. Rank held Lam Research as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.